13,14 In these patients, the potential of GLP-1 agonists not only can deliver improvement for the targeted conditions, but can reduce comorbidities, such as obesity, dyslipidemia, and cardiovascular disease
Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat
The FDA's BeSafeRx website provides verification tools to locate authorized pharmacy providers
And the trajectory is still upward, with patents on both Ozempic and Wegovy due to expire in China as early as 2026
Moreover, as understanding of GLP-1 biology expands, researchers are also investigating its effects on the gut-brain axis
Shanghais measures convert policy rhetoric into concrete enablers clinical pathways, payer innovation, and international outreach that together materially improve the commercialization prospects for cell therapy in the city